Legal & General Group’s Verona Pharma VRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.59M | Sell |
80,280
-61,465
| -43% | -$5.81M | ﹤0.01% | 1344 |
|
2025
Q1 | $8.99M | Sell |
141,745
-1,471
| -1% | -$93.3K | ﹤0.01% | 1189 |
|
2024
Q4 | $6.66M | Sell |
143,216
-234,788
| -62% | -$10.9M | ﹤0.01% | 1418 |
|
2024
Q3 | $10.9M | Sell |
378,004
-6,204
| -2% | -$179K | ﹤0.01% | 1135 |
|
2024
Q2 | $5.56M | Buy |
384,208
+304,635
| +383% | +$4.41M | ﹤0.01% | 1473 |
|
2024
Q1 | $1.28M | Sell |
79,573
-941
| -1% | -$15.1K | ﹤0.01% | 2109 |
|
2023
Q4 | $1.6M | Buy |
80,514
+12,664
| +19% | +$252K | ﹤0.01% | 2051 |
|
2023
Q3 | $1.11M | Buy |
67,850
+6,850
| +11% | +$112K | ﹤0.01% | 2156 |
|
2023
Q2 | $1.29M | Buy |
61,000
+36,624
| +150% | +$774K | ﹤0.01% | 2107 |
|
2023
Q1 | $490K | Sell |
24,376
-277
| -1% | -$5.57K | ﹤0.01% | 2318 |
|
2022
Q4 | $644K | Buy |
+24,653
| New | +$644K | ﹤0.01% | 2272 |
|